Skip to search formSkip to main contentSkip to account menu

nafazatrom

Known as: 1-(2-(beta-naphthyloxy)ethyl)-3-methyl-2- pyrazolin-5-one, 3H-pyrazol-3-one,2,4-dihydro-5-methyl-2-(2-(2-naphthalenyloxy)ethyl), 1-(2-(beta-naphthyloxy)ethyl)-3-methyl-2-pyrazolin-5-one 
A pyrazolinone derivative with potential antimetastatic activities. Nafazatrom, originally developed as an antithrombotic agent, inhibits the key… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
The role of lipoxygenase activation in the genesis of postischaemic myocardial dysfunction was investigated in open chest dogs… 
Review
1985
Review
1985
This article reviews the evidence we found in our study that the local generation of thromboxane and prostacyclin is one… 
1984
1984
Activation (defined as lysosomal enzyme secretion and generation of O(2) of rat neutrophils has been measured with the use of…